Critical

Thrombotic thrombocytopenic purpura

Microangiopathy · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A life-threatening thrombotic microangiopathy caused by severe ADAMTS13 deficiency, producing platelet-VWF microthrombi, microangiopathic haemolysis and organ ischaemia. Treat on microangiopathic haemolytic anaemia (MAHA) + thrombocytopenia alone — do NOT wait for the classic pentad. Untreated mortality is ~90%.

Figures & algorithms

Schistocytes (MAHA)
Schistocytes (MAHA)

Red flags

  • Fluctuating neurology — confusion, seizure, focal deficit, coma
  • Chest pain / troponin rise (cardiac microthrombi) — a major cause of death
  • Acute kidney injury
  • Profound thrombocytopenia with schistocytes on film

Assessment

Differential diagnosis

  • Haemolytic uraemic syndrome (HUS) — esp. E. coli O157 in children, renal-predominant
  • DIC (abnormal coagulation, a source of sepsis/malignancy)
  • HELLP / pregnancy-related TMA
  • Malignant hypertension
  • Severe sepsis
  • Heparin-induced thrombocytopenia
  • Evans syndrome
  • Drug-induced TMA

Investigations

  • FBC + blood film — SCHISTOCYTES + thrombocytopenia (the key finding)
  • LDH markedly raised; bilirubin up; haptoglobin low; reticulocytes up
  • Direct antiglobulin test (DAT/Coombs) NEGATIVE
  • Coagulation screen NORMAL (distinguishes from DIC)
  • U&E (renal), troponin (cardiac microthrombi)
  • ADAMTS13 activity (<10%) + inhibitor — SEND BEFORE giving any plasma
  • Pregnancy test

Management

  • Recognise MAHA + thrombocytopenia with NORMAL coagulation = TTP until proven otherwise
  • Immediate haematology + critical care referral — this is a haematological emergency
  • Start urgent PLASMA EXCHANGE (PEX) — the definitive treatment; do not wait for the ADAMTS13 result
  • High-dose corticosteroids (methylprednisolone / prednisolone)
  • Caplacizumab (anti-VWF) early where available
  • If PEX is delayed, give FFP infusion as a temporising bridge
  • Folic acid; rituximab for immune TTP
  • Do NOT transfuse platelets unless there is life-threatening bleeding

Drugs & doses

Plasma exchange (definitive)
Methylprednisolone / prednisolone
Caplacizumab
FFP (bridge only if PEX delayed)
Folic acid
Rituximab (immune TTP)

Disposition

Critical care / haematology for daily plasma exchange and monitoring.

Complications & pitfalls

  • Death (untreated ~90%)
  • Stroke, seizures
  • Myocardial infarction / arrhythmia
  • Acute kidney injury
  • Relapsing / refractory disease

Exam pearls

  • Normal PT/APTT with MAHA + thrombocytopenia points to TTP over DIC
  • PLATELET TRANSFUSION IS CONTRAINDICATED except for life-threatening haemorrhage — it fuels the microthrombi
  • Send ADAMTS13 (activity + inhibitor) BEFORE the first plasma/PEX
  • Start plasma exchange the same day — outcome is time-critical

TTP is a true haematological emergency — start plasma exchange urgently. Platelet transfusion can be fatal (drives microthrombi) unless there is life-threatening bleeding.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.